Levosimendan Reduces Lung Injury in a Canine Model of Cardiopulmonary Bypass |
Feng, Junbo
(The First Ward of Cardiovascular Surgery Department of the First Affiliated Hospital of Anhui Medical University)
Liu, Haiyuan (The Oncology Department of the Hefei Second People's Hospital) Chen, Jiayi (The First Ward of Cardiovascular Surgery Department of the First Affiliated Hospital of Anhui Medical University) Wang, Jiyuan (The First Ward of Cardiovascular Surgery Department of the First Affiliated Hospital of Anhui Medical University) Liu, Zhuang (The First Ward of Cardiovascular Surgery Department of the First Affiliated Hospital of Anhui Medical University) Ge, Shenglin (The First Ward of Cardiovascular Surgery Department of the First Affiliated Hospital of Anhui Medical University) |
1 | Qiu W, Zheng L, Gu H, Chen D, Chen Y. Comparison between adult and infant lung injury in a rabbit ischemia-reperfusion mode. J Thorac Cardiovasc Surg 2008;136:352-9. DOI |
2 | Kim JC, Shim JK, Lee S, Yoo YC, Yang SY, Kwak YL. Effect of combined remote ischemic preconditioning and postconditioning on pulmonary function in valvular heart surgery. Chest 2012;142:467-75. DOI |
3 | Rong J, Ye S, Liang MY, et al. Receptor for advanced glycation end products involved in lung ischemia reperfusion injury in cardiopulmonary bypass attenuated by controlled oxygen reperfusion in a canine model. ASAIO J 2013;59:302-8. DOI |
4 | Rong J, Ye S, Wu ZK, et al. Controlled oxygen reperfusion protects the lung against early ischemia-reperfusion injury in cardiopulmonary bypasses by downregulating high mobility group box 1. Exp Lung Res 2012;38:183-91. DOI |
5 | Wang C, Li D, Qian Y, Wang J, Jing H. Increased matrix metalloproteinase-9 activity and mRNA expression in lung injury following cardiopulmonary bypass. Lab Invest 2012;92:910-6. DOI |
6 | Qi D, Gao MX, Yu Y. Intratracheal antitumor necrosis factor- antibody attenuates lung tissue damage following cardiopulmonary bypass. Artif Organs 2013;37:142-9. DOI |
7 | Maniatis NA, Kardara M, Hecimovich D, et al. Role of caveolin-1 expression in the pathogenesis of pulmonary edema in ventilator-induced lung injury. Pulm Circ 2012; 2:452-60. DOI |
8 | Radovits T, Beller CJ, Groves JT, et al. Effects of FP15, a peroxynitrite decomposition catalyst on cardiac and pulmonary function after cardiopulmonary bypass. Eur J Cardiothorac Surg 2012;41:391-6. DOI |
9 | Gecit I, Kavak S, Yuksel MB, et al. Effect of short-term treatment with levosimendan on oxidative stress in renal tissues of rats. Toxicol Ind Health 2014;30,47-51. DOI |
10 | Paraskevaidis IA, Parissis JT, Th Kremastinos D. Anti-inflammatory and anti-apoptotic effects of levosimendan in decompensated heart failure: a novel mechanism of drug-induced improvement in contractile performance of the failing heart. Curt Med Chem Cardiovasc Hemaol Agents 2005;3:243-7. DOI |
11 | Markou T, Makridou Z, Galatou E, Lazou A. Multiple signalling pathways underlie the protective effect of levosimendan in cardiac myocytes. Eur J Pharmacol 2011;667:298-305. DOI |
12 | Caimmi PP, Molinari C, Uberti F, et al. Intracoronary levosimendan prevents myocardial ischemic damages and activates survival signaling through ATP-sensitive potassium channel and nitric oxide. Eur J Cardiothorac Surg 2011;39:e59-67. DOI |
13 | Hönisch A, Theuring N, Ebner B, Waqner C, Strasser RH, Weinbrenner C. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition. Basic Res Cardiol 2010;105:155-67. DOI |
14 | Ozturk T, Gok S, Nese N. Levosimendan attenuates reperfusion injury in an isolated perfused rat heart model. J Cardiothorac Vasc Anesth 2010;24:624-8. DOI |